Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

New England Journal of Medicine

Volumn 334, Issue 16, 1996, Pages 1018-1022

  Kuipers, Ernst J ^a   Lundell, Lars ^f   Klinkenberg Knol, Elly C ^a   Havu, Niilo ^g   Festen, Henk P M ^a   Liedman, Bengt ^f   Lamers, Cornelius B H W ^b   Jansen, Jan B M J ^c   Dalenbäck, Jan ^f   Snel, Pleun ^d   Nelis, G Frits ^e   Meuwissen, Stephan G M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e Sophia Hospital   (Netherlands)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RISK ASSESSMENT; SEROLOGY; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH FUNDOPLICATION; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; COHORT STUDIES; ESOPHAGITIS, PEPTIC; FEMALE; FUNDOPLICATION; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE;

EID: 15844369552     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199604183341603     Document Type: Article

References (31)

1. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975;2:58-60
2. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis, statistical calculations of cross-sectional data Int J Cancer 1985;35:173-7.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Schistosomes, liver flukes and Helicobacter pylori. Vol. 61 of IARC monographs on the evaluation of carcinogenic risks to humans Lyon, France. International Agency for Research on Cancer, 1994.
4. Kuipers EJ, Klinkenberg-Knol EC, Festen HPM, et al. Long-term omeprazole therapy does not affect Helicobacter pylori status in most patients Scand J Gastroenterol 1993;28:978-80.
5. Solcia E, Villani L, Fiocca R, et al Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol Suppl 1994,201.28-34.
6. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole Gut 1995;36:12-6.
7. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety Am J Gastroenterol 1995,90:1401-6
8. Stolte M, Bethke B, Blum AL, Sulser E, Stadelmann O. Antacid treatment has a deleterious effect on the severity and activity of gastritis of the corpus mucosa. Ir J Med Sci 1992;161:Suppl 10:6. abstract.
9. Roland M, Berstad A, Liavåg I. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol 1975;10:181-6
10. Meikle DD, Taylor TB, Truelove SC, Whitehead R. Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut 1976,17 719-28.
11. Danon SJ, O'Rourke JL, Moss ND, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology 1995;108:1386-95.
12. Savary M, Miller G. The esophagus: handbook and atlas of endoscopy. Solothurn, Switzerland: Grassman, 1987
13. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety Ann Intern Med 1994;121:161-7
14. Lundell L, Abrahamsson H, Ruth M, Rydberg L, Lönroth H, Olbe L. Total fundic wrap (Nissen-Rosetti) or semifundoplication (Toupet) in the surgical treatment of gastro-oesophageal reflux disease? Long-term results of a prospective, randomised clinical study Br J Surg (in press).
15. Garvey W, Fathi A, Bigelow F Modified Steiner for the demonstration of spirochetes. J Histotechnol 1985;8:15-7.
16. Sevier AC, Munger BL. A silver method for paraffin sections of neural issue. J Neuropathol Exp Neurol 1965;24:130-5.
17. Grimelius L, Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas Invest Cell Pathol 1980;3:3-12.
18. Price AB. The Sydney System: histological division J Gastroenterol Hepatol 1991;6:209-22.
19. Solcia E, Bordi C, Creutzfeldt W, et al Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988;41:185-200
20. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
21. Peña AS, Endtz HP, Offerhaus GJA, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989;44:131-41.
22. Armitage P, Berry G. Statistical methods in medical research. 2nd ed Oxford, England: Blackwell Scientific, 1987.
23. Lamberts R, Creutzfeldt W, Strüber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993,104:1356-70.
24. Modlin IM, Goldenring JR, Lawton GP, Hunt R Aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol 1994;89: 308-18.
25. Maaroos HI, Salupere V, Uibo R, Kekki M, Sipponen P Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand J Gastroenterol 1985,20:198-204
26. Havu N, Maaroos HI, Sipponen P. Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease Scand J Gastroenterol Suppl 1991;186.90-4.
27. Ihamaki T, Saukkonen M, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23-27 years' follow-up examinations Scand J Gastroenterol 1978;13:771-5.
28. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population, cohort follow-up. Cancer Res 1990,50:4737-40.
29. Villako K, Kekki M, Maaroos HI, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl 1991, 186:135-41
30. Jönsson KÅ, Ström M, Bodemar G, Norrby K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988;23.433-41.
31. Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment Digestion 1992;51 Suppl 1:82-92.